Increasing Consumer Demand for Genetic Screening Fuels the Growth of the Global Reproductive Genetics Market

 Reproductive Genetics is the branch of science that deals with the relationship between reproduction and genotype. It includes different tests & procedures to offer needful information about the probabilities of having a child in case of any specific genetic disorder. It also helps predict & prevent genetic disorders during reproductive procedures.

According to a new study by MarkNtel Advisors, the Global Reproductive Genetics Market is likely to grow at a CAGR of 12% during the forecast period, i.e., 2021-26. With the rising advanced stage pregnancies, there has been a surging demand for Pre-Natal Genetic Screening & Testing as a part of reproductive genetics to predict the risk of fetal chromosomal abnormalities depending on age.

Further, Pre-Natal testing became the need of the hour owing to the increasing number of cases of various genetic disorders, such as Down syndrome, cleft palate, sickle cell anemia, thalassemia, and fragile X syndrome. The leading industry players in the Global Reproductive Genetics Market are ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd, Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, and QIAGEN NV.



 

Among the numerous technological advancements witnessed by the healthcare industry, reproductive genetics has emerged as one of the most prominent ones to curb concerns related to genetic diseases. The increasing literacy has also promoted the understanding of people regarding personal genomic risks.

Based on the Application, the market divides into Aneuploidy, Structural Chromosomal Abnormality, and Single Gene Disorder. Of them all, Aneuploidy attained the largest share of the Global Reproductive Genetics Market. The surging number of Aneuploidy cases resulting in miscarriage is the most prominent aspect driving the need for reproductive genetic consultation and contributing to the overall market growth.

Of all regions, Europe is most likely to witness the fastest growth in the Global Reproductive Genetics Market during the forecast period. The persistent working of countries like France, Germany, the U.K., Spain, and Italy toward enhancing the adoption of such genetic testing for expecting parents & pregnant women across the region is the prime factor fueling the market growth in Europe.

There has been steady progress in the demand for various methods of reproductive genetic testing. Consequently, the rising availability of next-generation technologies & panels that allow the screening of genetic disorders at an early stage and the burgeoning demand for information is likely to fuel the growth of the Global Reproductive Genetics Market in the coming years.

Comments

Popular posts from this blog

How Rise in Number of Internet Users Fuels the Growth of the GCC E-Pharmacies Market?

Increasing Inclination of Oncologists and Physician to opt for Non-Invasive Diagnostic Procedures is Anticipated to Propel the Growth of the Global Liquid Biopsy market

Snowballing Demand for Medical Plastics in the Disposable Medical Products is Anticipated to Propel the Growth of Medical Plastic Converters market